Cargando…

Private equity and Covid-19()

We survey more than 200 private equity (PE) managers from firms with $1.9 trillion of assets under management (AUM) about their portfolio performance, decision-making and activities during the Covid-19 pandemic. Given that PE managers have significant incentives to maximize value, their actions duri...

Descripción completa

Detalles Bibliográficos
Autores principales: Gompers, Paul A., Kaplan, Steven N., Mukharlyamov, Vladimir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007931/
http://dx.doi.org/10.1016/j.jfi.2022.100968
_version_ 1784686938637205504
author Gompers, Paul A.
Kaplan, Steven N.
Mukharlyamov, Vladimir
author_facet Gompers, Paul A.
Kaplan, Steven N.
Mukharlyamov, Vladimir
author_sort Gompers, Paul A.
collection PubMed
description We survey more than 200 private equity (PE) managers from firms with $1.9 trillion of assets under management (AUM) about their portfolio performance, decision-making and activities during the Covid-19 pandemic. Given that PE managers have significant incentives to maximize value, their actions during the pandemic should indicate what they perceive as being important for both the preservation and creation of value. PE managers believe that 40% of their portfolio companies are moderately negatively affected and 10% are very negatively affected by the pandemic. The private equity managers—both investment and operating partners—are actively engaged in the operations, governance, and financing in all of their current portfolio companies. These activities are more intensively pursued in those companies that have been more severely affected by the Covid-19 pandemic. As a result of the pandemic, they expect the performance of their existing funds to decline. They are more pessimistic about that decline than the venture capitalists (VCs) surveyed in Gompers et al. (2021). Despite the pandemic, private equity managers are seeking new investments. Rather than focusing on cost cutting, PE investors place a much greater weight on revenue growth for value creation. Relative to the 2012 survey results reported in Gompers, Kaplan, and Mukharlyamov (2016), they appear to give a larger equity stake to management teams and target somewhat lower returns.
format Online
Article
Text
id pubmed-9007931
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-90079312022-04-14 Private equity and Covid-19() Gompers, Paul A. Kaplan, Steven N. Mukharlyamov, Vladimir Journal of Financial Intermediation Article We survey more than 200 private equity (PE) managers from firms with $1.9 trillion of assets under management (AUM) about their portfolio performance, decision-making and activities during the Covid-19 pandemic. Given that PE managers have significant incentives to maximize value, their actions during the pandemic should indicate what they perceive as being important for both the preservation and creation of value. PE managers believe that 40% of their portfolio companies are moderately negatively affected and 10% are very negatively affected by the pandemic. The private equity managers—both investment and operating partners—are actively engaged in the operations, governance, and financing in all of their current portfolio companies. These activities are more intensively pursued in those companies that have been more severely affected by the Covid-19 pandemic. As a result of the pandemic, they expect the performance of their existing funds to decline. They are more pessimistic about that decline than the venture capitalists (VCs) surveyed in Gompers et al. (2021). Despite the pandemic, private equity managers are seeking new investments. Rather than focusing on cost cutting, PE investors place a much greater weight on revenue growth for value creation. Relative to the 2012 survey results reported in Gompers, Kaplan, and Mukharlyamov (2016), they appear to give a larger equity stake to management teams and target somewhat lower returns. Elsevier Inc. 2022-07 2022-04-14 /pmc/articles/PMC9007931/ http://dx.doi.org/10.1016/j.jfi.2022.100968 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Gompers, Paul A.
Kaplan, Steven N.
Mukharlyamov, Vladimir
Private equity and Covid-19()
title Private equity and Covid-19()
title_full Private equity and Covid-19()
title_fullStr Private equity and Covid-19()
title_full_unstemmed Private equity and Covid-19()
title_short Private equity and Covid-19()
title_sort private equity and covid-19()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007931/
http://dx.doi.org/10.1016/j.jfi.2022.100968
work_keys_str_mv AT gomperspaula privateequityandcovid19
AT kaplanstevenn privateequityandcovid19
AT mukharlyamovvladimir privateequityandcovid19